BCLS Acquisition Corp.

General Information

(Note: This is a SPAC or blank-check IPO of 12.5 million Class A ordinary shares  – NOT units.) 

We intend to focus on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, we will pursue investments, primarily based in North America and Europe and selectively in other geographies, including Asia and emerging markets, in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies.

Our sponsor, BCLS Acquisition Holdings, LP, is an affiliate of Bain Capital Life Sciences. 

Employees: 0
Founded: 2020
Contact Information
Address 200 Clarendon Street Boston, Massachusetts 02116
Phone Number (617) 516-2000
Web Address
View Prospectus: BCLS Acquisition Corp.
Financial Information
Market Cap $160.75mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol BLSA
Exchange NASDAQ
Shares (millions): 12.5
Price range $10.00 - $10.00
Est. $ Volume $125.0 mil
Manager / Joint Managers Goldman Sachs/ Jefferies
Expected To Trade: 10/22/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change